Similar Papers

Paper Title
Journal
Date
Author
Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort.
G G Kovacs ... K Blennow
European Journal of Neurology | VOL. 24
G G Kovacs, et. al.G G Kovacs ... K Blennow
16 Aug 2017
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases
Andrew G B Thompson ... Ines Whitworth
Molecular Psychiatry | VOL. 26
Andrew G B Thompson, et. al.Andrew G B Thompson ... Ines Whitworth
05 Mar 2021
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers
Nicholas J Ashton ... Henrik Zetterberg
Alzheimer's Research & Therapy | VOL. 11
Nicholas J Ashton, et. al.Nicholas J Ashton ... Henrik Zetterberg
28 Nov 2019
Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus
A Jeppsson ... M Tullberg
Fluids and Barriers of the CNS | VOL. 20
A Jeppsson, et. al.A Jeppsson ... M Tullberg
06 Jul 2023
View more papers

More From: Journal of Neurology, Neurosurgery & Psychiatry

Paper Title
Journal
Date
Author
Linking LRP12 CGG repeat expansion to inherited peripheral neuropathy
Takahiro Hobara ... Hiroshi Takashima
Journal of Neurology, Neurosurgery & Psychiatry | VOL. 96
Takahiro Hobara, et. al.Takahiro Hobara ... Hiroshi Takashima
16 Jan 2025
Efgartigimod efficacy and safety in refractory myasthenia gravis: UK’s first real-world experience
Joana Moniz Dionísio ... Jennifer Spillane
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Joana Moniz Dionísio, et. al.Joana Moniz Dionísio ... Jennifer Spillane
11 Jan 2025
Depression and dementia: interrogating the causality of the relationship
Alvar Paris ... Sheena Waters
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
Alvar Paris, et. al.Alvar Paris ... Sheena Waters
11 Jan 2025
C5 complement inhibition and FcRn modulation in generalized myasthenia gravis. Fast-acting but short-lived therapies the use of which should prompt assertive escalation of conventional treatments
John Mcconville
Journal of Neurology, Neurosurgery & Psychiatry | VOL. -
John McconvilleJohn Mcconville
11 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.